A Phase I/II Study of the Janus Kinase (JAK)1 and 2...

Clinical Lymphoma Myeloma and Leukemia 2015 / 03 Vol. 15; Iss. 3

A Phase I/II Study of the Janus Kinase (JAK)1 and 2 Inhibitor Ruxolitinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Pemmaraju, Naveen, Kantarjian, Hagop, Kadia, Tapan, Cortes, Jorge, Borthakur, Gautam, Newberry, Kate, Garcia-Manero, Guillermo, Ravandi, Farhad, Jabbour, Elias, Dellasala, Sara, Pierce, Sherry, Versto
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2014.08.003
Date:
March, 2015
File:
PDF, 328 KB
english, 2015
Conversion to is in progress
Conversion to is failed